Virbac S.A.
VRBCF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.21B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $3.21 Billion |
|---|---|
| Enterprise Value | - |
| Annual dividend | $1.66 |
| Dividend yield | 0.46% |
| Earnings per Share | $17.98 |
| Beta | 0.78 |
| Outstanding Shares | 8,378,475 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 17.1 |
|---|---|
| PEG | 328.71 |
| Price to Sales | 1.1 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Last Earnings Call
Report Date
September 17, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
$877.10 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 23, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Virbac S.A.
6,442 employees
CEO: Paul Martingell
Founded in 1968 and based in Carros, France, Virbac S.A. is a prominent developer and distributor of a wide array of animal health products and services. The company's global operations extend across France, Europe, Latin America, North ...